News & Analysis on Clinical Trial Services & Contract Research And Development
According to a recent survey, the pharma industry spent an estimated $1.25 billion for each new molecular entity (NME) approved by the FDA in 2004. The figure represents the second consecutive year in which this figure has declined from the high of...
Italian processing machinery company IMA Group has decided to increase its investment in a Chinese joint venture to tap into a growth market at a time when its established territories in the West are showing lacklustre growth, reports Phil Taylor.
Novis is currently seeking experts to develop as science journalists across several of its pharmaceutical and food industry news services.
Scientists have developed a nanoparticle that can penetrate a tumour, cut off its blood supply and release a lethal dose of anti-cancer toxins, while leaving healthy cells unscathed.